双环环氨酸结合增强抗原交叉呈现和T细胞杀死,用于有效的癌症疫苗
Zhiguo Li1,2, Tengyao Wang1,3, Weifan Li1,3
1Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
Journal of the American Chemical Society
|February 17, 2026
概括
一种新的癌症疫苗策略使用点击化学 (DBCO) 来增强树突细胞的抗原吸收,促进细胞毒性T淋巴细胞 (CTL) 反应,以改善瘤控制和免疫记忆.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 癌症疫苗旨在预防和治疗瘤,但由于细胞毒性T淋巴细胞 (CTL) 激活不良,其有效性有限.
- 传统疫苗与树突细胞交叉呈现作斗争,这是有效的CTL反应的关键步骤.
- 现有的辅助剂往往表现出不良的生物相容性和全身毒性,限制了它们的临床使用.
研究的目的:
- 为了研究DBCO的潜力,一个点击化学试剂,作为癌症疫苗的辅助剂类免疫增强剂.
- 评估DBCO促进树突细胞交叉呈现和增强抗原特异性CTL反应的能力.
- 在临床前瘤模型中评估DBCO修饰的癌症疫苗的疗效.
主要方法:
- 蛋白质抗原的DBCO修饰以增强树突细胞吸收和MHC I类交叉呈现.
- 研究NF-κB/iNOS信号通路在DBCO介导的免疫增强中的作用.
- 在小鼠模型中评估瘤控制,免疫记忆和转移抑制,使用DBCO结合疫苗,单独和与抗PD-1疗法.
主要成果:
- DBCO结合显著增加了树突细胞的抗原吸收,并促进了MHC I类交叉呈现.
- DBCO激活了NF-κB/iNOS信号通路,在体外增强了CTL激活.
- 经过DBCO修饰的疫苗改善了瘤控制,建立了长期免疫记忆,并与体内抗PD-1疗法结合抑制了转移.
结论:
- 双环氧氨酸 (DBCO) 作为一种有效的辅助剂类分子,增强癌症疫苗诱导的CTL反应.
- 点击化学为开发下一代癌症疫苗提供了一个有前途的平台,其临床疗效得到了提高.
- 用DBCO修饰的疫苗是癌症免疫治疗的可行策略,特别是与检查点抑制剂结合使用时.
相关概念视频
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Vaccinations
52.0K
Overview
52.0K
Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
Antigens Involved in Adaptive Immunity
1.6K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.6K
T Cell Activation and Clonal Selection
16.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.4K


